[HTML][HTML] New opportunities and challenges of natural products research: When target identification meets single-cell multiomics

Y Zhu, Z Ouyang, H Du, M Wang, J Wang, H Sun… - … Pharmaceutica Sinica B, 2022 - Elsevier
Natural products, and especially the active ingredients found in traditional Chinese medicine
(TCM), have a thousand-year-long history of clinical use and a strong theoretical basis in …

How chemokines organize the tumour microenvironment

TR Mempel, JK Lill, LM Altenburger - Nature Reviews Cancer, 2024 - nature.com
For our immune system to contain or eliminate malignant solid tumours, both myeloid and
lymphoid haematopoietic cells must not only extravasate from the bloodstream into the …

Exosomes: A potential tool for immunotherapy of ovarian cancer

X Gong, H Chi, DF Strohmer, AT Teichmann… - Frontiers in …, 2023 - frontiersin.org
Ovarian cancer is a malignant tumor of the female reproductive system, with a very poor
prognosis and high mortality rates. Chemotherapy and radiotherapy are the most common …

[HTML][HTML] Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation

G Deng, L Zhou, B Wang, X Sun, Q Zhang… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background The loss of tumor antigens and depletion of CD8 T cells caused by the PD-1/PD-
L1 pathway are important factors for tumor immune escape. In recent years, there has been …

CXCR6 expressing T cells: Functions and role in the control of tumors

N Mabrouk, T Tran, I Sam, I Pourmir, N Gruel… - Frontiers in …, 2022 - frontiersin.org
CXCR6 is a receptor for the chemokine CXCL16, which exists as a membrane or soluble
form. CXCR6 is a marker for resident memory T (TRM) cells that plays a role in …

Tumor immunogenic cell death as a mediator of intratumor CD8 T-cell recruitment

N Roussot, F Ghiringhelli, C Rébé - Cells, 2022 - mdpi.com
The success of anticancer treatments relies on a long-term response which can be mediated
by the immune system. Thus, the concept of immunogenic cell death (ICD) describes the …

Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM

A Xiong, J Zhang, Y Chen, Y Zhang, F Yang - EBioMedicine, 2022 - thelancet.com
Background Glioblastoma (GBM) is the most aggressive type of primary brain tumor and is
often resistant to current therapies. Tumor microenvironment-centered therapies may …

Role of the CXCR6/CXCL16 axis in autoimmune diseases

N Bao, B Fu, X Zhong, S Jia, Z Ren, H Wang… - International …, 2023 - Elsevier
Abstract The C–X–C motif ligand 16, or CXCL16, is a chemokine that belongs to the ELR−
CXC subfamily. Its function is to bind to the chemokine receptor CXCR6, which is a G protein …

CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells

Y Zhang, J Hu, K Ji, S Jiang, Y Dong, L Sun, J Wang… - Cell Reports …, 2023 - cell.com
Although radiotherapy (RT) has achieved great success in the treatment of non-small cell
lung cancer (NSCLC), local relapses still occur and abscopal effects are rarely seen even …

Physiology of chemokines in the cancer microenvironment

D Drouillard, BT Craig… - American Journal of …, 2023 - journals.physiology.org
Chemokines are chemotactic cytokines whose canonical functions govern movement of
receptor-expressing cells along chemical gradients. Chemokines are a physiological system …